Skip to content
DraconiticResearch
Search Sources API
182,544 studies31 sourcesUpdated 58 min ago
PreprintAll rights reservedbioRxiv

Development of CYP8B1-specific inhibitors for metabolic diseases

  • Z. Fang
  • A. R. L. Agua
  • J. Jossart
  • N. Sharma
  • X. Lyu
  • Z. Wang
  • S. Zhang
  • J. Sun
  • L. Shi
  • J. Ayard
  • M. Chang
  • J. Liu
8 more authors
  • K. Kou
  • J. Shively
  • A. Garcia-Ocana
  • D. Horne
  • H. Yin
  • L. Jin
  • J. J. P. Perry
  • W. Huang1
  1. 1Beckman Research Institute, City of Hope National Medical Center
Read full textPDFDOICite

Related

  1. Development landscape of ketohexokinase-C (KHK-C) inhibitors for fructose-driven metabolic disorders: from hit discovery to clinical trials.
    Sri Venkata Gopal Ainapurapu, Timir Naskar, Ajwin Joseph Martin +1
    RSC medicinal chemistryPeer-reviewedCC BYFull textEndocrinology & metabolismEurope PMC
  2. Chemical-Specific Metabolic Disruption during Early Zebrafish Development is Modulated by the Microbiome.
    Nanna Fyhrquist, Lydia Gugescu, Emma Wincent +1
    Environment & health (Washington, D.C.)Peer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  3. Chinese expert consensus on the treatment of immune‑mediated inflammatory diseases with Janus kinase inhibitors.
    Xiaofeng Zeng, Jianzhong Zhang, Minhu Chen +1
    Rheumatology and immunology researchPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Bruton Tyrosine Kinase Inhibitors in Immune-Mediated Skin Diseases: Current Evidence and Future Directions
    Zihan Wang, Junchen He, Ting Zhang +6
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0Full textGeneral medicineCrossrefEurope PMC
  5. Editorial: Herbal medicine for the treatment of chronic metabolic diseases, volume II
    Yongsheng Chen
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textEndocrinology & metabolismCrossref

Cite

BibTeXRIS
BibTeX
@misc{fang2026development,
  title = {{Development of CYP8B1-specific inhibitors for metabolic diseases}},
  author = {Z. Fang and A. R. L. Agua and J. Jossart and N. Sharma and X. Lyu and Z. Wang and S. Zhang and J. Sun and L. Shi and J. Ayard and M. Chang and J. Liu and K. Kou and J. Shively and A. Garcia-Ocana and D. Horne and H. Yin and L. Jin and J. J. P. Perry and W. Huang},
  howpublished = {bioRxiv},
  year = {2026},
  month = oct,
  doi = {10.64898/2026.10.20.760253},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.20.760253v1},
}
RIS
TY  - UNPB
TI  - Development of CYP8B1-specific inhibitors for metabolic diseases
AU  - Z. Fang
AU  - A. R. L. Agua
AU  - J. Jossart
AU  - N. Sharma
AU  - X. Lyu
AU  - Z. Wang
AU  - S. Zhang
AU  - J. Sun
AU  - L. Shi
AU  - J. Ayard
AU  - M. Chang
AU  - J. Liu
AU  - K. Kou
AU  - J. Shively
AU  - A. Garcia-Ocana
AU  - D. Horne
AU  - H. Yin
AU  - L. Jin
AU  - J. J. P. Perry
AU  - W. Huang
PY  - 2026
DA  - 2026/10/20
PB  - bioRxiv
DO  - 10.64898/2026.10.20.760253
UR  - https://www.biorxiv.org/content/10.64898/2026.10.20.760253v1
ER  -